BR101549
BR101549 is a non-TZD agonist of PPARγ. BR101549 activates PPARγ to the level of Pioglitazone in vitro. BR101549 can control blood glucose level in mouse model. BR101549 can be studied in anti-diabetic research[1].
Product Specifications
CAS Number
2252478-54-7
UNSPSC
12352005
Target
PPAR
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Smiles
O=C(OCC)CC1=C(C(C)C)N=C(CCCC)N(CC2=CC=C(C3=CC=CC=C3C(N4)=NOC4=O)C=C2)C1=O
Molecular Formula
C30H34N4O5
Molecular Weight
530.61
References & Citations
[1]Choung, W., et al., (2019) . Identification of BR101549 as a lead candidate of non-TZD PPARγ agonist for the treatment of type 2 diabetes: Proof-of-concept evaluation and SAR. Bioorganic & medicinal chemistry letters, 29 (4), 631-637.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![2-[ (Cyclopropylcarbonyl) amino]benzoic acid](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
